Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database

CONCLUSIONS: Histological subtypes are involved in determining the heterogeneity of HER2+ MBC patient prognosis, which is helpful to guide the prognosis prediction and monitoring of HER2+ breast cancer patients in clinics.PMID:37605516 | DOI:10.1002/cam4.6469

Source: Cancer Control - August 22, 2023 Category: Cancer & Oncology Authors: Yajie Wang Yiran Liang Fangzhou Ye Dan Luo Yuhan Jin Yaming Li Wenjing Zhao Bing Chen Lijuan Wang Qifeng Yang Source Type: research